Has guideline development gone astray? YesBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c306 (Published 29 January 2010) Cite this as: BMJ 2010;340:c306
- R Grol, director
- 1Scientific Institute for Quality of Health Care, Radboud University Nijmegen Medical Centre, PO Box 9101, 114, 6500 HB Nijmegen, Netherlands
It is a long time since clinical guidelines were seen as cookbook medicine and a threat to professional autonomy. Nowadays, evidence based guidelines are considered one of the major efforts to improve patient care. Development of guidelines has progressed enormously, with many organisations (including the National Institute for Health and Clinical Excellence in the UK) using validated methods such as the AGREE instrument.1 Clinical guidelines are valid if they are developed in a rigorous way, independently of vested interests of their developers, and if they support decision making in practice and affect actual care. But are current guidelines meeting these criteria? I have concerns.
For guidelines to have an impact on actual care, they need to be integrated with other quality improvement initiatives, such as performance measurement and quality improvement programmes. This requires intensive collaboration between the organisations responsible for these tasks,2 which is lacking in most countries. Expert guideline developers, usually clinicians and epidemiologists, often have …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.